Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging

被引:16
作者
Jentzen W. [1 ]
Richter M. [1 ]
Nagarajah J. [1 ]
Poeppel T.D. [1 ]
Brandau W. [1 ]
Dawes C. [2 ]
Bockisch A. [1 ]
Binse I. [1 ]
机构
[1] Klinik für Nuklearmedizin, Universität Duisburg-Essen, Hufelandstrasse 55, Essen
[2] Department of Oral Biology, University of Manitoba, 780 Bannatyne Avenue, Winnipeg, Manitoba
关键词
Dosimetry; Iodine-124; Radioiodine therapy; Salivary gland; Thyroid carcinoma;
D O I
10.1186/s40658-014-0100-1
中图分类号
学科分类号
摘要
Background: The goal of this prospective study was to estimate the absorbed (radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under chewing-gum stimulation using 124I positron emission tomography (PET)/computed tomography (CT) imaging. Methods: Duplex ultrasonography was conducted in three test persons for visual comparison of the glandular blood flow with three different stimulation types (no stimulation, chewing tasteless gum base, sucking on lemon slices). Ten patients with newly diagnosed differentiated thyroid cancer received 124I PET/CT dosimetry after thyroidectomy and prior to radioiodine therapy. Patients underwent a series of three 124I PET/CT scans (4, 24, and ≥96 h after administration of 23 MBq 124I). They were instructed to chew gum base (tasteless) approximately 20 min after ingesting the 124I-containing capsule in the course of the first day. Absorbed doses per administered 131I activity to the salivary glands were calculated and compared with the previously published results of the lemon-juice stimulation and non-stimulation groups. Results: The sonograms in the three test persons showed that glandular blood perfusion by lemon-juice stimulation was clearly increased compared with non-stimulation or chewing of gum base. The sonogram comparison between the chewing-gum stimulation and non-stimulation demonstrated a minor increase of blood flow for the gum base-stimulated salivary glands. The mean ± standard deviation of the absorbed dose per activity under chewing-gum stimulation for the submandibular and parotid glands (within parentheses) was 0.22 ± 0.09 Gy/GBq (0.22 ± 0.08 Gy/GBq). Compared with the absorbed doses of the non-stimulation group, 0.24 ± 0.08 Gy/GBq (0.21 ± 0.05 Gy/GBq), those of the chewing-gum stimulation group showed no significant change (P > 0.60), but the absorbed doses of the lemon-juice stimulation group, 0.35 ± 0.14 Gy/GBq (0.33 ± 0.09 Gy/GBq), were significantly higher (P < 0.04) than those of the chewing-gum stimulation group. Conclusions: The results suggest that salivary flow induced by chewing gum base does not cause a significant reduction of the salivary gland absorbed dose compared with that in the non-stimulation group. The increased blood flow appears to be a decisive factor causing the increased 131I absorbed doses in the lemon-juice stimulation group. © 2014, Jentzen et al.; licensee Springer.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 17 条
[1]  
Luster M., Clarke S.E., Dietlein M., Lassmann M., Lind P., Oyen W.J., Tennvall J., Bombardieri E., Guidelines for radioiodine therapy of differentiated thyroid cancer, Eur J Nucl Med Mol Imaging, 35, pp. 1941-1959, (2008)
[2]  
Lee S.L., Complications of radioactive iodine treatment of thyroid carcinoma, J Natl Compr Canc Netw, 8, pp. 1277-1286, (2010)
[3]  
Hyer S., Kong A., Pratt B., Harmer C., Salivary gland toxicity after radioiodine therapy for thyroid cancer, Clin Oncol, 19, pp. 83-86, (2007)
[4]  
La Perle K.M., Kim D.C., Hall N.C., Bobbey A., Shen D.H., Nagy R.S., Wakely P.E., Lehman A., Jarjoura D., Jhiang S.M., Modulation of sodium/iodide symporter expression in the salivary gland, Thyroid, 23, pp. 1029-1036, (2013)
[5]  
Noaparast Z., Hosseinimehr S.J., Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, J Future Oncol, 9, pp. 1145-1159, (2013)
[6]  
Van Nostrand D., Atkins F., Bandaru V.V., Chennupati S.P., Moreau S., Burman K., Wartofsky L., Salivary gland protection with sialagogues: a case study, Thyroid, 19, pp. 1005-1008, (2009)
[7]  
Van Nostrand D., Bandaru V., Chennupati S., Wexler J., Kulkarni K., Atkins F., Mete M., Gadwale G., Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice, Thyroid, 20, pp. 1113-1119, (2010)
[8]  
Nakada K., Ishibashi T., Takei T., Hirata K., Shinohara K., Katoh S., Zhao S., Tamaki N., Noguchi Y., Noguchi S., Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?, J Nucl Med, 46, pp. 261-266, (2005)
[9]  
Liu B., Kuang A., Huang R., Zhao Z., Zeng Y., Wang J., Tian R., Influence of vitamin C on salivary absorbed dose of <sup>131</sup>I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial, J Nucl Med, 51, pp. 618-623, (2010)
[10]  
Jentzen W., Balschuweit D., Schmitz J., Freudenberg L., Eising E., Hilbel T., Bockisch A., Stahl A., The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using <sup>124</sup>I PET(/CT) imaging, Eur J Nucl Med Mol Imaging, 37, pp. 2298-2306, (2010)